Loss of PAR3 in breast tumors also caused mislocalization and activation of atypical PKC, which triggered JAK-dependent activation of STAT3 and induction of matrix metalloproteinase 9 (MMP9) to promote destruction of the extracellular matrix, invasion, and metastasis [3]. Here, MMP9 is linked to breast neoplasm.